4.8 Article

Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platforms

Journal

NUCLEIC ACIDS RESEARCH
Volume 33, Issue 18, Pages 5914-5923

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gki890

Keywords

-

Funding

  1. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050688, P60AR047784, P30AR047363, P01AR048929] Funding Source: NIH RePORTER
  2. NIAMS NIH HHS [P60 AR047784, AR048929, R01 AR050688, P01 AR048929, AR47363, AR50688, P30 AR047363, AR47784] Funding Source: Medline
  3. NIGMS NIH HHS [GM076880] Funding Source: Medline

Ask authors/readers for more resources

The growth in popularity of RNA expression microarrays has been accompanied by concerns about the reliability of the data especially when comparing between different platforms. Here, we present an evaluation of the reproducibility of microarray results using two platforms, Affymetrix GeneChips and Illumina BeadArrays. The study design is based on a dilution series of two human tissues (blood and placenta), tested in duplicate on each platform. The results of a comparison between the platforms indicate very high agreement, particularly for genes which are predicted to be differentially expressed between the two tissues. Agreement was strongly correlated with the level of expression of a gene. Concordance was also improved when probes on the two platforms could be identified as being likely to target the same set of transcripts of a given gene. These results shed light on the causes or failures of agreement across microarray platforms. The set of probes we found to be most highly reproducible can be used by others to help increase confidence in analyses of other data sets using these platforms.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available